Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
276,495,626
-
Share change
-
+5,459,628
-
Total reported value
-
$9,857,311,052
-
Put/Call ratio
-
71%
-
Price per share
-
$35.64
-
Number of holders
-
814
-
Value change
-
+$194,467,459
-
Number of buys
-
356
-
Number of sells
-
329
Institutional Holders of GSK plc - SPONSORED ADR (GSK) as of Q2 2023
As of 30 Jun 2023 GSK plc - SPONSORED ADR (GSK) had 814 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 276,495,626 shares of stock of the company.
Largest 10 holders included Dodge & Cox, FMR LLC, Fisher Asset Management, LLC, JTC Employer Solutions Trustee Ltd, PRICE T ROWE ASSOCIATES INC /MD/, PRIMECAP MANAGEMENT CO/CA/, GOLDMAN SACHS GROUP INC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, Royal Bank of Canada, and MORGAN STANLEY.
This table shows 815 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.